No Data
No Data
Noxopharm Expands Partnership With Victoria Medical Research Institute
Noxopharm Ltd: Appendix 4D and FY2025 Half Year Financial Report
Noxopharm Ltd. Announces Issuance of New Unquoted Equity Securities
Noxopharm Ltd: Noxopharm enhances 2024 cash position via R&D rebate
ASX Small-Cap Stocks to Watch
Noxopharm Announces Key 2024 AGM Details